Agilent Technologies (A) Shareholder Hoplite Capital Management LP Has Decreased Its Stake as Stock Value Declined; Celgene (CELG) Holder Polen Capital Management Has Decreased Position as Shares Declined

April 16, 2018 - By Vivian Park

Agilent Technologies, Inc. (NYSE:A) Logo

John Lykouretzos decreased its stake in Agilent Technologies Inc (A) by 17.35% based on its latest 2017Q4 regulatory filing with the SEC. Hoplite Capital Management Lp sold 432,656 shares as the company’s stock declined 0.52% with the market. The hedge fund run by John Lykouretzos held 2.06M shares of the capital goods company at the end of 2017Q4, valued at $137.99M, down from 2.49M at the end of the previous reported quarter. Hoplite Capital Management Lp who had been investing in Agilent Technologies Inc for a number of months, seems to be less bullish one the $21.95B market cap company. The stock increased 1.28% or $0.86 during the last trading session, reaching $68.07. About 563,089 shares traded. Agilent Technologies, Inc. (NYSE:A) has risen 25.85% since April 16, 2017 and is uptrending. It has outperformed by 14.30% the S&P500.

Polen Capital Management Llc decreased its stake in Celgene Corp (CELG) by 2.26% based on its latest 2017Q4 regulatory filing with the SEC. Polen Capital Management Llc sold 118,154 shares as the company’s stock declined 19.30% with the market. The institutional investor held 5.11M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $533.61 million, down from 5.23 million at the end of the previous reported quarter. Polen Capital Management Llc who had been investing in Celgene Corp for a number of months, seems to be less bullish one the $68.08B market cap company. The stock increased 1.24% or $1.11 during the last trading session, reaching $90.51. About 2.06 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 16, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Since December 18, 2017, it had 0 buys, and 9 sales for $9.10 million activity. On Thursday, January 18 the insider McMullen Michael R. sold $1.58M. The insider Doak Mark sold $1.06 million. Another trade for 5,000 shares valued at $340,450 was sold by FIELDS HEIDI. Kaltenbach Patrick sold 4,000 shares worth $269,113.

Among 15 analysts covering Agilent Technologies (NYSE:A), 11 have Buy rating, 0 Sell and 4 Hold. Therefore 73% are positive. Agilent Technologies had 58 analyst reports since August 14, 2015 according to SRatingsIntel. On Tuesday, December 8 the stock rating was upgraded by Goldman Sachs to “Buy”. The stock of Agilent Technologies, Inc. (NYSE:A) has “Overweight” rating given on Thursday, February 15 by JP Morgan. Barclays Capital maintained it with “Buy” rating and $71.0 target in Tuesday, November 21 report. BTIG Research maintained Agilent Technologies, Inc. (NYSE:A) on Friday, August 14 with “Buy” rating. The firm has “Overweight” rating given on Friday, October 6 by Morgan Stanley. The company was initiated on Tuesday, September 26 by Goldman Sachs. The stock has “Hold” rating by Deutsche Bank on Thursday, January 7. Jefferies maintained the shares of A in report on Wednesday, September 20 with “Buy” rating. The stock has “Hold” rating by Cowen & Co on Wednesday, December 20. The stock of Agilent Technologies, Inc. (NYSE:A) has “Overweight” rating given on Wednesday, March 15 by Morgan Stanley.

Analysts await Agilent Technologies, Inc. (NYSE:A) to report earnings on May, 28. They expect $0.64 earnings per share, up 10.34% or $0.06 from last year’s $0.58 per share. A’s profit will be $206.39M for 26.59 P/E if the $0.64 EPS becomes a reality. After $0.66 actual earnings per share reported by Agilent Technologies, Inc. for the previous quarter, Wall Street now forecasts -3.03% negative EPS growth.

Investors sentiment decreased to 0.95 in 2017 Q4. Its down 0.45, from 1.4 in 2017Q3. It dived, as 40 investors sold A shares while 198 reduced holdings. 62 funds opened positions while 164 raised stakes. 269.93 million shares or 0.89% more from 267.56 million shares in 2017Q3 were reported. Boston Advsrs stated it has 0.07% in Agilent Technologies, Inc. (NYSE:A). 14,933 are owned by Meiji Yasuda Life Ins. Arrowstreet Capital LP holds 1.73M shares. Proshare Advsrs Limited Liability Co accumulated 81,517 shares. Barclays Public Ltd Company reported 0.05% of its portfolio in Agilent Technologies, Inc. (NYSE:A). Churchill Mgmt has 80,126 shares for 0.12% of their portfolio. Moreover, Arizona State Retirement Systems has 0.09% invested in Agilent Technologies, Inc. (NYSE:A). Northwestern Mutual Wealth Mgmt accumulated 665 shares or 0% of the stock. Carroll Fincl Assocs accumulated 0% or 200 shares. Duncker Streett reported 0.02% stake. Vanguard Gp stated it has 23.85 million shares. Plante Moran Financial Advsr Limited Liability Company holds 0.01% or 235 shares in its portfolio. Federated Pa owns 0.06% invested in Agilent Technologies, Inc. (NYSE:A) for 312,639 shares. Ontario Teachers Pension Plan Board holds 0.1% or 126,844 shares. Cardinal Mgmt holds 63,714 shares.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on April, 26. They expect $1.78 earnings per share, up 16.34% or $0.25 from last year’s $1.53 per share. CELG’s profit will be $1.34B for 12.71 P/E if the $1.78 EPS becomes a reality. After $1.87 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -4.81% negative EPS growth.

Investors sentiment decreased to 0.83 in 2017 Q4. Its down 0.34, from 1.17 in 2017Q3. It dived, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. 56,115 are owned by Thompson. Fiduciary invested in 26,054 shares. 231,106 are held by Fisher Asset Mgmt Ltd Liability. Fincl holds 0.28% or 25,000 shares. 11,477 are held by Johnson Fin Gru. First Natl Tru, a Pennsylvania-based fund reported 10,638 shares. Brave Asset stated it has 39,416 shares or 2.14% of all its holdings. Kentucky-based Field & Main Natl Bank has invested 0.73% in Celgene Corporation (NASDAQ:CELG). Private Ocean Ltd owns 322 shares for 0.02% of their portfolio. Rathbone Brothers Public Ltd has invested 0.17% of its portfolio in Celgene Corporation (NASDAQ:CELG). Pinnacle Fincl Prtnrs, Tennessee-based fund reported 9,790 shares. Rosenbaum Jay D owns 0.38% invested in Celgene Corporation (NASDAQ:CELG) for 2,000 shares. Pggm Investments has 343,679 shares for 0.2% of their portfolio. Pinnacle Wealth Mngmt Advisory Grp Incorporated Lc reported 0.12% in Celgene Corporation (NASDAQ:CELG). Sg Americas Securities Lc holds 0.08% in Celgene Corporation (NASDAQ:CELG) or 79,501 shares.

Since February 8, 2018, it had 1 buying transaction, and 3 insider sales for $3.58 million activity. $299,594 worth of stock was bought by Alles Mark J on Thursday, February 8. KAPLAN GILLA had sold 18,500 shares worth $1.77M. Another trade for 13,370 shares valued at $1.26M was sold by MARIO ERNEST.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: